SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-03-001094
Filing Date
2003-03-31
Accepted
2003-03-31 11:21:47
Documents
12
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS INC. 10-K w84502e10vk.htm 10-K 887612
3 CERTIFICATE OF AMENDMENT w84502exv3w01d.txt EX-3.01D 3030
4 AMENDED AND RESTATED BY-LAWS w84502exv3w02.txt EX-3.02 39205
5 AMENDMENT TO 1993 OPTION PLAN w84502exv10w01f.txt EX-10.01F 1104
6 FORM OF STOCK OPTION AGREEMENT w84502exv10w01g.txt EX-10.01G 36926
7 FORM OF STOCK OPTION AGREEMENT-1998 w84502exv10w02c.txt EX-10.02C 36126
8 FORM OF STOCK OPTION AGREEMENT w84502exv10w03d.txt EX-10.03D 22078
9 EMPLOYEE STOCK PURCHASE PLAN w84502exv10w05.txt EX-10.05 32610
10 2002 STOCK OPTION AND INCENTIVE PLAN w84502exv10w06.htm EX-10.06 172576
11 FORM OF SEVERANCE AGREEMENT w84502exv10w11.htm EX-10.11 3552
12 SUBSIDIARIES OF REGISTRANT w84502exv21w01.txt EX-21.01 767
13 CONSENT OF KPMG LLP w84502exv23w01.txt EX-23.01 1337
  Complete submission text file 0000950133-03-001094.txt   1239828
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23736 | Film No.: 03627947
SIC: 2834 Pharmaceutical Preparations